| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, September 2007, p. 6001-6011, Vol. 27, No. 17
0270-7306/07/$08.00+0 doi:10.1128/MCB.01807-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Dermatology and USC/Norris Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, California 90033,1 VA Greater Los Angeles Healthcare System, Sepulveda, California 913432
Received 22 September 2006/ Returned for modification 16 November 2006/ Accepted 14 June 2007
| ABSTRACT |
|---|
|
|
|---|
/Nck1 versus Grb4/Nckß/Nck2 side-by-side in the process of mammalian neuritogenesis. Here we show that permanent genetic silencing of Nckß, but not Nck
, completely blocked nerve growth factor-induced neurite outgrowth in PC12 cells and dramatically disrupted the axon and dendrite tree in primary rat cortical neurons. By screening for changes among the components reportedly present in complex with Nck, we found that the steady-state level of paxillin was significantly reduced in Nckß knockdown, but not Nck
knockdown, neurons. Interestingly, Nckß knockdown did not affect the paxillin level in glial cells and several other cell types of various tissue origins. Genetic silencing of paxillin blocked neuritogenesis, just like Nckß knockdown. Reintroducing a nondegradable Nckß into Nckß short interfering RNA-expressing PC12 cells rescued paxillin from down-regulation and allowed the resumption of neuritogenesis. Forced expression of paxillin in Nckß knockdown PC12 also rescued its capacity for neuritogenesis. Finally, Nckß, but not Nck
, binds strongly to paxillin and treatment of the neurons with proteosome inhibitors prevented paxillin down-regulation in Nckß knockdown neurons. Thus, Nckß maintains paxillin stability during neuritogenesis. | INTRODUCTION |
|---|
|
|
|---|
There are two mammalian Nck genes, encoding Nck/Nck
/Nck1 and Grb4/Nckß/Nck2. In humans, they are located on chromosome 3 and chromosome 2, respectively (4, 12). A simple answer is still lacking for the question of whether Nck
and Nckß exist as mutually compensating partners or whether each of them has its own cell and/or tissue-specific function. It has been shown that mice deficient for either Nck
or Nckß are viable, whereas the elimination of both Nck
and Nckß results in lethality at embryonic day 9.5. Mouse embryonic fibroblast cells derived from the Nck double-knockout mice exhibited defects in cell migration in vitro (1). Therefore, the authors of this study concluded that Nck
and Nckß are functionally redundant during mouse development. However, an increasing number of studies have also provided evidence that Nck
and Nckß have rather nonoverlapping functions in various type of cells (5, 6, 14, 19, 21, 25). So far, no Nck
- or Nckß-specific downstream target proteins have been identified, and it has obviously become critical to further understand the underlying mechanisms.
What tissue/cell model system should be used to study Nck
versus Nckß? In fact, the most clearly demonstrated cell type-specific function of Nck is its role in mediating the signals for neuronal cell differentiation. Drosophila Nck, dreadlocks, is essential for axon guidance during eye development via a receptor to p21rac/cdc42-activated kinase (Pak) to actin cytoskeleton pathway (8, 11). In mammalian cells, Nck plays a critical role in the bidirectional signals mediated by membrane-anchored ephrins and their Eph family tyrosine kinase receptors (23). One example is the reverse signaling by Ephrin-B3, which regulates cell-cell interactions during axon pathfinding and hindbrain segmentation (6). Another example is the Disabled 1-mediated Reelin signal that regulates neuronal placement by remodeling the actin cytoskeleton (19). Therefore, we turned to neuronal systems for answers. In this current study, we compared the importance of Nck
and Nckß in two types of neuronal cells from rat: the pheochromocytoma cell line PC12 and primary cortical neurons. Our results show that Nckß, but not Nck
, is essential for the induction and maintenance of neuronal cell differentiation, i.e., neuritogenesis. More importantly, we found that the mechanism for the Nckß-mediated differentiation of neurons is through its ability to maintain the intracellular level of paxillin, a well-characterized protein that links plasma membrane receptors with actin cytoskeleton-orchestrated events. In contrast, Nck
has no effect on the intracellular levels of paxillin in neuronal cells. Moreover, the Nckß-paxillin relationship in neurons was not found in rat glial cells and cells originating from a number of other tissues.
| MATERIALS AND METHODS |
|---|
|
|
|---|
- and anti-Nckß-specific antibodies were generated as previously described by us (4). Anti-Pak1 (sc-882) and anti-FAK (c-20), anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase), and all horseradish peroxidase-conjugated secondary antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). MG132 was purchased from Calbiochem. The inactive derivative, MG132-In, was synthesized by Synthetic biomolecules (San Diego, CA). The enhanced chemiluminescence Western blotting detection kit (RPN2106) was from Amersham (Buckinghamshire, United Kingdom). All other reagents and supplies, unless otherwise indicated, were from VWR (Bristol, CT) or SIGMA.
GFP, Nck, Nck RNA interference, paxillin, and paxillin RNA interference in lentiviral vectors.
The lentivirus-derived vector, pRRLsinhCMV, had cDNAs encoding enhanced green fluorescent protein (EGFP) (at EcoRV), Nck
(at XbaI/PstI), or Nckß (at XhoI/BamHI) inserted according to a procedure previously described (15). Chicken paxillin-EGFP cDNA (a gift from Alan F. Horwitz, University of Virginia, Charlottesville, VA) was subcloned into pRRLsinhCMV at XbaI and EcoRI. We used the siRNA Selection Program as described previously to identify possible target sequences (27). Two to three short interfering RNA (siRNA) sequences were cloned into the lentiviral siRNA delivery vector, FG-12, as previously described (20). The following siRNA sequences (sense) were selected against the rat Nck or paxillin cDNAs and used in the subsequent studies: GATGATAGCTTTGTTGATC (siNck
1), GAGAGAGAGGATGAATTGT (siNck
2), GCATCTATGACCTCAACAT (siNckß1), GAGGGCGACTTCCTCATTA (siNckß2), GGCCCATCTTGGATAAAGT (siPaxillin-1), GGACAACCCTACTGTGAAA (siPaxillin-2), and GGACAACCCTACTGTGAAA (siPaxillin-3).
Production of lentiviral stocks and infection.
The pRRLsinhCMV and FG-12 constructs, together with packaging vectors pCMV
R8.2 and pMDG, were used to cotransfect 293T cells as previously described (3). Typical viral titers were 1 x 106 to 7 x 106 transduction units/ml without concentration and 5 x 107 to 5 x 108 after ultracentrifugation, using GFP directly measured by fluorescence-activated cell sorter (FACS) analysis as the marker. Cell infection and the determination of infection efficiency, as monitored by EGFP expression, were carried out as previously described (15). Usually, the cells were subjected to biochemical and cell differentiation experiments five days after infection with FG-12 and forty-eight hours after infection with pRRLsinh-CMV.
Measurement of transgene expression or endogenous gene down-regulation. Nck and paxillin gene products were detected by immunoblotting of the lysates of infected cells (>5 x 105 cells/experimental condition) using antibodies against the corresponding gene products. The lower part of the same blotting membrane was blotted with an anti-GAPDH antibody as the control for equal sample loading. ECL autographs with unsaturated exposure were used to assess the increases (over their corresponding GAPDH bands) by scanning densitometry. The results of one representative of three identical but independent experiments are shown (15).
Neurite outgrowth, gene rescue, and morphological analyses. PC12 cells (50,000) were seeded into each well of six-well plates which were precoated with 20 µg/ml of type I collagen and incubated overnight in RPMI 1640 with only 1% horse serum. NGF (100 ng/ml) was added to the cultures to induce neurite outgrowth. The neurite outgrowth of these cells was visualized daily for 4 consecutive days under a dark-field microscope (OLYMPUS IMT-2) with a 10x (for an overall view of cell population) or 20x (neurite or axon/dendrite tree structure) objective. The images were recorded in JEPEG by an attached charge-coupled-device camera using SCION Image software (version 6.1). Under each experimental condition, 80 to 120 cells were randomly selected from randomly selected microscopic fields, recorded, and analyzed. The neurite outgrowth of PC12 cells was also monitored by the ratio of the neurite length to the cell body diameter. Significant neurite outgrowth was arbitrarily defined as neurites with extensions greater than two times the cell body length.
To rescue the defect in PC12 cells expressing siNckß, the cells were reinfected with virus carrying genes for Nck
, siNckß-resistant Nckß (Nckß-r), or GFP-paxillin. Forty-eight hours after the infection, half of the cells were subjected to Western blotting analysis and the other half were used for the morphological neurite outgrowth assays.
Forty-eight hours after culturing the dissociated primary cortical neurons, we infected the neurons with lentiviruses carrying the indicated constructs. Five days after the infection, individual images were captured from randomly selected fields under a fluorescence microscope (TE-2000U Eclipse; Nikon). All the images were imported to Image J (NIH) for analyses of total dendrite length. Total dendrite length refers to the length of all dendrites and branches of a single neuron. Each experiment was repeated at least three times. All data are expressed as the means plus or minus the standard errors of the results of separate experiments. The differences between the means were determined by the Student t test for unpaired samples, and those with a P value of <0.05 were considered significant.
GST pull-down and coimmunoprecipitation assays.
Purified glutathione S-transferase (GST), GST-Nck
, or GST-Nckß bound to glutathione-agarose beads (5 µg each) was incubated overnight with postnuclear lysates (
0.5 to 0.7 mg of total proteins) of PC12 cells in lysis buffer (20 mM Tris base, 50 mM NaCl, 50 mM sodium pyrophosphate, 30 mM NaF, 100 µM orthovanadate, 5 µM zinc chloride, 2 mM iodoacetic acid, 1.0% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, and a protease inhibitor cocktail). The beads were washed three times with the same lysis buffer, and the bound proteins were dissociated from the beads by boiling at 95°C for 5 min in 1x sample buffer. The supernatants were subjected to Western blotting analysis with antipaxillin antibodies. Total lysates (40 to 60 µg of total proteins) were included as the control.
To compare the in vivo interactions between Nck
or Nckß and paxillin, we overexpressed Nck
or Nckß in 293T cells by transfection. Lysates of the cells (4 x 106) were immunoprecipitated with antipaxillin antibodies. The immunoprecipitates were resolved in a sodium dodecyl sulfate gel, transferred onto a nitrocellulose membrane, and immunoblotted with either antipaxillin antibodies or anti-Nck
or anti-Nckß antibodies, respectively. Likely due to the low affinities of the anti-Nck
and anti-Nckß antibodies, we were unable to clearly detect endogenous Nck by antipaxillin antibody coimmunoprecipitation.
| RESULTS |
|---|
|
|
|---|
have distinct functions in NGF-induced neurite outgrowth.
NGF induces PC12 cells to produce dramatic neurite outgrowth, which is the characteristic of sympathetic neurons. The initiation of the neurite outgrowth becomes detectable after 24 to 48 h of NGF exposure. However, it takes 3 to 4 more days for these cells to differentiate and form neurites that are several times longer than the width of the cell body (2, 9). Therefore, the clear and inducible phenotype of this neuronal cell line was used to determine whether Nck
and Nckß have distinct or redundant functions. We genetically silenced the endogenous Nck
or Nckß expression by using RNA interference. To ensure the specificity, two siRNA sequences against different regions in each rat Nck gene were designed and constructed into the lentiviral FG-12 system next to a GFP reporter gene (20). Since the FG-12 vector integrates into the host chromosome following infection, the siRNA expression becomes permanent in the host cells. This is particularly important for long-term biological assays, such as neurite outgrowth in neurons.
First, to test the infection efficiency of the FG-12 system in PC12 cells, the cells were infected with the control FG-12-GFP vector and subjected to FACS analyses after 48 h. As shown in Fig. 1A, 96% of the cells in culture expressed GFP. Next, we tested the effectiveness of siNck
and siNckß on the down-regulation of their target genes. As shown in Fig. 1B, the two siRNA constructs against Nck
dramatically down-regulated the endogenous Nck
(panel a, lanes 3 and 4) in comparison to the levels of Nck
in FG-12 vector- or control siLacZ-infected cells (panel a, lanes 1 and 2). In contrast, as expected, siNck
had no effect on the endogenous levels of Nckß (panel b, lanes 3 and 4 versus lanes 1 and 2). Likewise, the two siNckß constructs significantly down-regulated the endogenous Nckß (panel b, lanes 5 and 6) in comparison to the levels in cells infected with vector alone or siLacZ control (panel b, lanes 1 and 2). However, the two siNckß constructs did not affect endogenous Nck
levels (panel a, lanes 5 and 6). The results of immunoblotting duplicate membranes with anti-GAPDH antibodies showed that all lanes were loaded with similar amounts of total proteins (panel c).
|
increased the basal level of neurite presence even in the absence of NGF (panel i versus panels a and e). In the presence of NGF, these cells showed earlier onset of induced neurite outgrowth (panel j versus panels b and f). Down-regulation of Nckß did not alter the basal level of neurite outgrowth (panel m); however, it completely blocked NGF-stimulated neurite outgrowth over the time period (panels n to p). The second siRNA constructs (i.e., siNck
2 and siNckß1) gave results similar to those for siNck
1 and siNckß2, and the data are presented as the general quantitation of the neurite outgrowth under the various conditions shown in Fig. 1D. Thus, Nckß is essential for NGF signaling to induce neurite outgrowth.
Nckß is required for maintaining axonal and dendrite tree architecture in primary rat neurons.
To investigate whether Nckß plays a similar role in primary neurons, we infected isolated rat cortical neurons with the same set of siRNAs against Nck. As shown in Fig. 2A, the FG-12 system offered more than 90% gene transduction efficiency in these fully differentiated neurons. When these neurons were infected with siNck
1 or siNckß2, as shown in Fig. 2B, we detected down-regulation of the endogenous Nck
(panel a, lane 3) or Nckß (panel b, lane 4), respectively, in comparison to the levels in the cells infected with the FG-12 vector or siLacZ control (lanes 1 and 2). When the axon and dendrite structures in these cells were analyzed under a fluorescence microscope, as shown in Fig. 2C, the neurons infected with either vector or siLacZ control maintained their constitutive axon and dendrite networks (panels a and b). Likewise, down-regulation of Nck
did not cause any significant changes in the cells' phenotype (panel c). However, down-regulation of Nckß dramatically reduced the number of axons and dendrites per neuron and deteriorated the overall network architecture. When we visualized the effects of Nckß knockdown on individual neurons, as shown in Fig. 2D, we observed that neurons infected with vector alone (panel e), siLacZ (panel f), or siNck
1 (panel g) still maintained the fully differentiated phenotype. However, neurons infected with siNckß2 showed severely disrupted axon and dendrite networks (panel h). Therefore, Nckß also has a unique role in the induction and maintenance of neuritogenesis in primary neurons. The quantitation of the axon and dendrite structure is shown in Fig. 2E.
|
did not alter the cellular levels of focal adhesion kinase (FAK) (panel b) or p21Rac/Cdc24-activated kinase 1 (PAK1) (panel c). Interestingly, down-regulation of Nckß (panel a, lane 4), but not Nck
(panel a, lane 3), significantly reduced the intracellular level of paxillin (panel d, lane 4 versus lane 3). GAPDH was used as the loading control (panel e). We confirmed a similar observation in primary neurons. As shown in Fig. 3B, down-regulation of Nckß caused a concomitant down-regulation of paxillin (panel a, lane 4 versus lanes 1 and 2). In contrast, Nck
knockdown showed little effect (panel a, lane 3). As expected, down-regulation of Nckß did not affect FAK or PAK in the cells (panels b and c, lane 4).
|
on paxillin levels. As shown in Fig. 3C, infecting PC12 cells with increasing titers of siNckß1 or siNckß2 virus resulted in a dose-dependent down-regulation of the endogenous paxillin (panel a, lanes 3 to 8 versus lanes 1 and 2). This down-regulation of paxillin correlated well with the degree of Nckß knockdown (panel b, lanes 3 to 8 versus lanes 1 and 2). In contrast, as shown in Fig. 3D, dose-dependent down-regulation of Nck
(panel b, lanes 3 to 6) had little effect on the paxillin level (panel a), even though the down-regulation of Nck
was nearly complete (panel b, lane 6). In both experiments, GAPDH was used as the loading control (panel c). Because paxillin is critical for mouse development (10), we wondered, if paxillin had been totally missing in Nckß–/– mice, how the mice would have survived. Therefore, we speculated that Nckß may not control the stability of paxillin in all cell types. We tested this possibility by screening several types of cells from a variety of origins, together with PC12 cells. As shown in Fig. 3E, Nckß knockdown caused, as expected, more than an 85% reduction of paxillin in PC12 cells (lane 6). In contrast, the absence of Nckß did not affect the paxillin levels in primary human dermal fibroblasts (lanes 1 and 2), embryonic kidney epithelial cell line 293T (lanes 3 and 4), primary human dermal microvascular endothelial cells (lanes 9 and 10), human breast epithelial cancer cell line MCF-7 (lanes 11 and 12), or primary human epidermal keratinocytes (lanes 13 and 14). More intriguingly, we found that the paxillin level remained unchanged even in a glioma cell line, U89MG, after down-regulation of Nckß (lanes 7 and 8). However, as in the neurons, down-regulation of Nckß also caused a concomitant reduction of paxillin in the cervical epithelial cancer cells, HeLa (lanes 15 and 16). At this time, it remains to be tested whether this result was due to the transformed cellular context in HeLa cells. Therefore, it would be interesting to test primary epithelial cells of breast and cervix. Finally, the down-regulation of paxillin remained the same in Nckß knockdown PC12 cells cultured either in the presence or in the absence of NGF (Fig. 3F, lane 4 versus lane 2).
We then studied the possible mechanism by which Nckß maintains, whereas Nck
does not, the steady-state paxillin level in neuronal cells. First, we carried out GST-Nckß and GST-Nck
pull-down assays using lysates of PC12 cells. As shown in Fig. 3G, GST alone did not bind any detectable amount of paxillin (lane 2) with reference to that of the total lysate control (lane 1). GST-Nck
pulled down a small amount of paxillin (<0.1%). In contrast, GST-Nckß pulled down significantly more paxillin (
10% of the total paxillin in the lysate, lane 4). Unfortunately, due to the low affinities of the anti-Nck
and anti-Nckß antibodies in both Western blots and immunoprecipitations, we were unable to detect any endogenous Nck that otherwise might coimmunoprecipitate with paxillin. Therefore, as shown in Fig. 3H, we transiently overexpressed Nck
(panel a, lane 2) and Nckß (panel d, lane 2) in 293T cells and coimmunoprecipitated them with antibodies against the endogenous paxillin (panels c and f). Clearly, significantly more Nckß (panel e, lane 2) than Nck
(panel b, lane 2) was coimmunoprecipitated by antipaxillin antibodies.
Didier and colleagues showed that paxillin is a target for posttranslational modification by ubiquitination (7). Therefore, we asked if the reduction of paxillin in Nckß-knockdown neuronal cells is due to protein degradation. We tested two proteasome inhibitors, MG132 and lactacystin, on paxillin down-regulation in PC12 cells expressing siNckß. Among the three types of proteases in proteasomes, MG132 is known to inhibit chymotrypsin-like and calpain-like activities, whereas lactacystin inhibits chymotrypsin-like and trypsin-like activities. As shown in Fig. 4A, MG132 treatment of Nckß-knockdown PC12 cells partially (50 to 70%) restored the paxillin level (panel a, lanes 4 to 6 versus lane 3). In contrast, an inactive MG132 derivative (benzyloxycaronyl-leucinyl-leucinyl-leucinyl-amide) was unable to do the same (panel c, lane 3). As expected, MG132 was unable to rescue the down-regulation of paxillin caused by siRNA against paxillin itself (Fig. 4B, panel e, lanes 4 to 6 versus lane 3). Lactacystin showed much weaker rescuing effect. As shown in Fig. 4C, we detected a maximum of 15% to 20% restoration of the steady-state paxillin level following lactacystin treatments (panel g, lanes 5 and 6 versus lanes 1 and 2). These results suggest that Nckß controls paxillin stability by a posttranslational mechanism in neurons.
|
|
and siNckß controls (lanes 6 and 7). In contrast, none of the siPaxillins showed any effect on the Nckß or FAK levels (Fig. 6B). Since a GFP gene is coexpressed with both the control vector and the vectors with inserted siPaxillins, we analyzed the axon and dendrite structures of the neurons under a fluorescence microscope. As shown in Fig. 6C (left column, panels a to d), the extent of disruption is correlated with the degree of paxillin knockdown (panels b, c, and d versus panel a). The siPaxillin-1 construct almost completely demolished the axon and dendrite network (panel b versus panel a). When single neurons were visualized, as shown in Fig. 6C (right column, panels e to h), down-regulation of paxillin was seen to decrease the number of axons and dendrites per neuron in correlation with the degree of paxillin knockdown (panels f to h versus panel e). Thus, paxillin, like Nckß, is essential for maintaining neuritogenesis.
|
was included as a control. As shown in Fig. 7A, successful expression of Nckß-r in control and siNckß-expressing PC12 cells was demonstrated by immunoblotting the membrane with anti-Nckß antibodies (panel a, lanes 2 and 4). As expected, down-regulation of Nckß caused a decreased paxillin level (panel b, lane 3 versus lanes 1). While coexpression of Nckß-r did not affect paxillin levels in cells expressing the siLacZ control (lane 2 versus lane 1), it overrode siNckß2-induced down-regulation of paxillin and restored the normal cellular level of paxillin (lane 4 versus lane 3). Immunoblotting of a duplicate membrane with an anti-PAK1 antibody was used as the loading control (panel c). In contrast, the overexpression of wild-type Nck
was unable to rescue siNckß-induced down-regulation of paxillin (Fig. 7B, panel b, lane 4 versus lane 3). Overexpressed Nck
itself was demonstrated by immunoblotting the lower part of the same membrane with an anti-Nck
antibody (panel a, lanes 2 and 4).
|
was unable to do the same in these cells (panel f versus panel d). We expected that reexpression of paxillin should bypass the Nckß knockdown blockade of neuritogenesis in PC12 cells. As shown in Fig. 7C, the expression of a higher-molecular-weight GFP-paxillin fusion protein was detected in the infected cells (panel a, lanes 3 and 4), but not in the siLacZ control cells (lanes 1 and 2). As expected, the overexpressed paxillin was unable to rescue the siNckß-induced down-regulation of Nckß (panel b, lane 4 versus lane 2), confirming that paxillin acts downstream of Nckß. When these cells were subjected to neurite outgrowth assays in response to NGF, as shown in Fig. 8A, the overexpression of GST-paxillin in the siNckß-expressing cells restored the production of NGF-induced neurite outgrowth (panel j versus panel i). The quantitation of the data is shown in Fig. 8B. Taken together, these results establish the pathway of Nckß leading to paxillin stability leading to neuritogenesis.
|
| DISCUSSION |
|---|
|
|
|---|
, is selected to mediate cell surface cues in supporting and/or maintaining neuritogenesis. In doing so, Nckß binds and maintains the physiological level of paxillin, a critical focal adhesion molecule. Like Nckß–/– neurons, neurons with paxillin knockdown failed to produce axons and dendrites. More intriguingly, Nckß does not appear to affect paxillin stability in most of the other cell types studied. We conclude that Nckß plays a critical role in neuronal differentiation.
Efforts were made to verify that the down-regulation of paxillin is specifically due to the down-regulation of Nckß, rather than a cross-reactivity of Nckß siRNAs with paxillin mRNA. First, neither of the two selective siRNA sequences has any significant homology with paxillin cDNA or any other existing rat mRNAs (according to an NCBI BLAST examination of RefSeq and UniGene databases). Second, two completely different Nckß siRNA sequences showed similar effects on paxillin down-regulation, whereas none of the siRNAs against Nck
showed any effects on the paxillin levels. Third, reexpressing an engineered siRNA-resistant Nckß (Nckß-r) fully restored the cellular paxillin level. Finally, the reexpression of Nckß-r or paxillin in Nckß-down-regulated PC12 cells rescued the ability of the cells to undergo neurite outgrowth in response to NGF. We found that GST-Nckß pulled down significantly more paxillin than GST-Nck
and antipaxillin antibodies coimmunoprecipitated more Nckß than Nck
. These results suggest that Nckß prevents paxillin degradation by binding, directly or indirectly, to paxillin.
The inhibition of protein degradation by two potent proteasome inhibitors, MG132 and lactacystin, showed differential effects on paxillin in PC12 cells expressing siNckß. MG132 showed a much stronger protecting effect than lactacystin, suggesting that Nckß controls paxillin stability via a posttranslational mechanism. Turner reported the formation of a Nck-Pak-PIX-PKL-paxillin-FAK multiple protein complex in rat brain lysate (24). However, we did not detect any significant down-regulation of Pak or FAK in the cells expressing siNckß. Assuming the above complex also exists in PC12 cells, our finding indicates that Nckß selectively controls the stability of certain components within the protein complex, such as paxillin, but not other components, such as FAK and Pak.
How does one integrate our findings with the observation that Nckß–/– (Nck
+/+) and Nck
–/– (Nckß+/+) mice are developmentally viable and normal (1)? Specifically, if Nckß controls the paxillin stability in neurons, one might expect that Nckß–/– (Nck
+/+) mice would exhibit mental retardation and other neurological symptoms. There have been no answers to these questions, since the Nckß–/– (Nck
+/+) and Nck
–/– (Nckß+/+) mice have not been evaluated for possible neurological pathology. In fact, the individual and noncompensating roles of Nck
and Nckß are more evident in the central nervous system than other tissues in the mice (Tony Pawson, personal communication). Vaynberg and colleagues suggested an alternative explanation. They proposed that "chronic" alteration of Nck genes, such as in mice, is less harmful than an "acute" inhibition of the same gene in somatic cells (25). It may also depend upon the developmental stage of a given signaling pathway, which may only become indispensable in adult animals and tissues. For instance, embryonic fibroblast cell lines derived from Nckß–/– or Nck
–/– mice both exhibited defects in migration in response to platelet-derived growth factor-BB (21). Therefore, the platelet-derived growth factor-BB signaling may be compensated during the embryonic stage of mouse development and become indispensable in fully differentiated somatic cells.
| ACKNOWLEDGMENTS |
|---|
This work was supported by Public Health Service grant GM/AR67100-01 from the NIH (to W.L.).
| FOOTNOTES |
|---|
Published ahead of print on 25 June 2007. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Chao, M. V., and B. L. Hempstead. 1995. p75 and Trk: a two-receptor system. Trends Neurosci. 18:321-326.[CrossRef][Medline]
3. Chen, M., W. Li, J. Fan, N. Kasahara, and D. Woodley. 2003. An efficient gene transduction system for studying gene function in primary human dermal fibroblasts and epidermal keratinocytes. Clin. Exp. Dermatol. 28:193-199.[CrossRef][Medline]
4. Chen, M., H. She, E. M. Davis, C. M. Spicer, L. Kim, R. Ren, M. M. Le Beau, and W. Li. 1998. Identification of Nck family genes, chromosomal localization, expression, and signaling specificity. J. Biol. Chem. 273:25171-25178.
5. Chen, M., H. She, A. Kim, D. T. Woodley, and W. Li. 2000. Nckß adapter regulates actin polymerization in NIH 3T3 fibroblasts in response to platelet-derived growth factor bb. Mol. Cell. Biol. 20:7867-7880.
6. Cowan, C. A., and M. Henkemeyer. 2001. The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals. Nature 413:174-179.[CrossRef][Medline]
7. Didier, C., L. Broday, A. Bhoumik, S. Israeli, S. Takahashi, K. Nakayama, S. M. Thomas, C. E. Turner, S. Henderson, H. Sabe, and Z. Ronai. 2003. RNF5, a RING finger protein that regulates cell motility by targeting paxillin ubiquitination and altered localization. Mol. Cell. Biol. 23:5331-5345.
8. Garrity, P. A., Y. Rao, I. Salecker, J. McGlade, T. Pawson, and S. L. Zipursky. 1996. Drosophila photoreceptor axon guidance and targeting requires the dreadlocks SH2/SH3 adapter protein. Cell 85:639-650.[CrossRef][Medline]
9. Greene, L. A., and A. S. Tischler. 1976. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73:2424-2428.
10. Hagel, M., E. L. George, A. Kim, R. Tamimi, S. L. Opitz, C. E. Turner, A. Imamoto, and S. M. Thomas. 2002. The adapter protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol. Cell. Biol. 22:901-915.
11. Hing, H., J. Xiao, N. Harden, L. Lim, and S. L. Zipursky. 1999. Pak functions downstream of Dock to regulate photoreceptor axon guidance in Drosophila. Cell 97:853-863.[CrossRef][Medline]
12. Huebner, K., K. Kastury, T. Druck, A. E. Salcini, L. Lanfrancone, G. Pelicci, E. Lowenstein, W. Li, S. H. Park, L. Cannizzaro, et al. 1994. Chromosome locations of genes encoding human signal transduction adapter proteins, Nck (NCK), Shc (SHC1), and Grb2 (GRB2). Genomics 22:281-287.[CrossRef][Medline]
13. Kaplan, D. R., and F. D. Miller. 2000. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10:381-391.[CrossRef][Medline]
14. Kempiak, S. J., H. Yamaguchi, C. Sarmiento, M. Sidani, M. Ghosh, R. J. Eddy, V. Desmarais, M. Way, J. Condeelis, and J. E. Segall. 2005. A neural Wiskott-Aldrich syndrome protein-mediated pathway for localized activation of actin polymerization that is regulated by cortactin. J. Biol. Chem. 280:5836-5842.
15. Li, W., J. Fan, M. Chen, S. Guan, D. Sawcer, G. M. Bokoch, and D. T. Woodley. 2004. Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB. Mol. Biol. Cell 15:294-309.
16. Li, W., J. Fan, and D. T. Woodley. 2001. Nck/Dock: an adapter between cell surface receptors and the actin cytoskeleton. Oncogene 20:6403-6417.[CrossRef][Medline]
17. O'Neill, K., S. Chen, and R. D. Brinton. 2004. Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease. Exp. Neurol. 185:63-80.[CrossRef][Medline]
18. Pawson, T., and P. Nash. 2003. Assembly of cell regulatory systems through protein interaction domains. Science 300:445-452.
19. Pramatarova, A., P. G. Ochalski, K. Chen, A. Gropman, S. Myers, K. T. Min, and B. W. Howell. 2003. Nckß interacts with tyrosine-phosphorylated disabled 1 and redistributes in Reelin-stimulated neurons. Mol. Cell. Biol. 23:7210-7221.
20. Qin, X. F., D. S. An, I. S. Chen, and D. Baltimore. 2003. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci USA 100:183-188.
21. Rivera, G. M., S. Antoku, S. Gelkop, N. Y. Shin, S. K. Hanks, T. Pawson, and B. J. Mayer. 2006. Requirement of Nck adaptors for actin dynamics and cell migration stimulated by platelet-derived growth factor B. Proc. Natl. Acad. Sci. USA 103:9536-9541.
22. Schlessinger, J. 1994. SH2/SH3 signaling proteins. Curr. Opin. Genet. Dev. 4:25-30.[CrossRef][Medline]
23. Stein, E., U. Huynh-Do, A. A. Lane, D. P. Cerretti, and T. O. Daniel. 1998. Nck recruitment to Eph receptor, EphB1/ELK, couples ligand activation to c-Jun kinase. J. Biol. Chem. 273:1303-1308.
24. Turner, C. E. 2000. Paxillin and focal adhesion signaling. Nat. Cell Biol. 2:E231-E236.[CrossRef][Medline]
25. Vaynberg, J., T. Fukuda, K. Chen, O. Vinogradova, A. Velyvis, Y. Tu, L. Ng, C. Wu, and J. Qin. 2005. Structure of an ultraweak protein-protein complex and its crucial role in regulation of cell morphology and motility. Mol. Cell 17:513-523.[CrossRef][Medline]
26. Vindis, C., T. Teli, D. P. Cerretti, C. E. Turner, and U. Huynh-Do. 2004. EphB1-mediated cell migration requires the phosphorylation of paxillin at Tyr-31/Tyr-118. J. Biol. Chem. 279:27965-27970.
27. Yuan, B., R. Latek, M. Hossbach, T. Tuschl, and F. Lewitter. 2004. siRNA Selection Server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 32:W130-W134.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|